Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

RSS XML

Resultados 1 - 2 de 2

1 Próxima > >>

Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).

Fury, M G; Sherman, E J; Rao, S S; Wolden, S; Smith-Marrone, S; Mueller, B; Ng, K K; Dutta, P R; Gelblum, D Y; Lee, J L; Shen, R; Kurz, S; Katabi, N; Haque, S; Lee, N Y; Pfister, D G.

Ann Oncol ; 25(3): 689-694, 2014 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-24496920

High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer.

Pisters, K M; Tyson, L B; Tong, W; Fleisher, M; Miller, V A; Grant, S C; Pfister, D G; Rigas, J R; Densmore, C L; Krol, G; Heelan, R T; Sirotnak, F M; Bertino, J R; Kris, M G.

Clin Cancer Res ; 2(11): 1819-24, 1996 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-9816135

Resultados 1 - 2 de 2

1 Próxima > >>

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).

High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancer.